SYSTEMIC SCLERODERMA
Clinical trials for SYSTEMIC SCLERODERMA explained in plain language.
Never miss a new study
Get alerted when new SYSTEMIC SCLERODERMA trials appear
Sign up with your email to follow new studies for SYSTEMIC SCLERODERMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope: immunotherapy trial targets cancer in patients with autoimmune disorders
Disease control Recruiting nowThis study is for people who have both an autoimmune disease (like rheumatoid arthritis, lupus, or multiple sclerosis) and advanced cancer that has spread or cannot be removed. It tests a drug called nivolumab, which helps the immune system fight cancer, given alone or with other…
Matched conditions: SYSTEMIC SCLERODERMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 30, 2026 15:50 UTC
-
New radiation technique may shield organs in scleroderma stem cell therapy
Disease control Recruiting nowThis early study tests whether a precise type of total body radiation (IMRT) combined with chemotherapy can safely prepare people with severe systemic sclerosis for a stem cell transplant using their own cells. The goal is to reduce radiation exposure to the lungs and kidneys whi…
Matched conditions: SYSTEMIC SCLERODERMA
Phase: EARLY_PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Apr 29, 2026 15:02 UTC
-
Family study aims to unlock secrets of rare autoimmune disease
Knowledge-focused Recruiting nowThis study looks at families where more than one person has systemic scleroderma, a rare autoimmune disease. By studying these families, researchers hope to find clues about how the disease develops and progresses. The study involves 20 adults with the condition and their first-d…
Matched conditions: SYSTEMIC SCLERODERMA
Sponsor: University Hospital, Strasbourg, France • Aim: Knowledge-focused
Last updated May 01, 2026 14:33 UTC